PharmaEssentia (FRA:8Z1) Total Liabilities: €148.1 Mil (As of Dec. 2025)


FRA:8Z1 PharmaEssentia Corp FRA:8Z1
82 GF Score
Price €15.50
GF Value €14.50
! 6 Warning Signs
View Full Analysis

What is PharmaEssentia Total Liabilities?

PharmaEssentia FRA:8Z1 82 Total Liabilities is €148.1 Mil as of Dec. 2025. GuruFocus rates FRA:8Z1 with a GF Score™ of 82/100 and a GF Value™ of €14.50. The stock has 6 warning signs investors should review.

PharmaEssentia's Total Liabilities for the quarter that ended in Dec. 2025 was €148.1 Mil.

PharmaEssentia's quarterly Total Liabilities increased from Jun. 2025 (€124.64 Mil) to Sep. 2025 (€131.88 Mil) and increased from Sep. 2025 (€131.88 Mil) to Dec. 2025 (€148.07 Mil).

PharmaEssentia's annual Total Liabilities increased from Dec. 2023 (€97.45 Mil) to Dec. 2024 (€105.33 Mil) and increased from Dec. 2024 (€105.33 Mil) to Dec. 2025 (€148.07 Mil).

PharmaEssentia Total Liabilities Historical Data

* Premium members only.

The historical data trend for PharmaEssentia's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaEssentia Total Liabilities Chart

PharmaEssentia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 62.12 98.29 97.45 105.33 148.07

PharmaEssentia Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 105.33 109.40 124.64 131.88 148.07
FRA:8Z1
82GF Score
PharmaEssentia Corp FRA:8Z1
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaEssentia Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

PharmaEssentia's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=127.497+(17.644+2.645
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0.283+0)
=148.1

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=1019.04-870.971
=148.1

PharmaEssentia's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=127.497+(17.644+2.645
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0.283+0)
=148.1

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=1019.04-870.971
=148.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €148.1 Mil mean?
PharmaEssentia (FRA:8Z1) has a Total Liabilities of €148.1 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PharmaEssentia and its competitors.
Is PharmaEssentia's Total Liabilities too high?
PharmaEssentia's current Total Liabilities is €148.1 Mil. Overall, PharmaEssentia has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does PharmaEssentia's Total Liabilities compare to ZTS and UTHR?
PharmaEssentia's Total Liabilities of €148.1 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PharmaEssentia and its competitors. PharmaEssentia's current Total Liabilities is €148.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaEssentia stock overvalued right now?
PharmaEssentia (FRA:8Z1) has a current Total Liabilities of €148.1 Mil. The stock's GF Value™ is €14.50, compared to a current price of €15.50 — trading 6.9% above its estimated fair value. The current Total Liabilities is €148.1 Mil. PharmaEssentia's overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For PharmaEssentia (FRA:8Z1), the current Total Liabilities is €148.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PharmaEssentia (FRA:8Z1) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaEssentia stock appears to be overvalued. The current stock price of €15.50 is trading 6.9% above its estimated GF Value™ of €14.50.

Key valuation signals for FRA:8Z1:

  • Total Liabilities: €148.1 Mil
  • GF Value™: €14.50 vs. price of €15.50 (6.9% above fair value)
  • GF Score™: 82/100 with 6 warning signs

No single metric tells the full story. See the FRA:8Z1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PharmaEssentia Business Description

Other Exchanges 6446:Taiwan
Address 13th Floor, No.3, Park Street, Nangang District, Taipei, TWN, 115
PharmaEssentia Corp engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API and new drug patterns developments. Its products include BESREMi, Ropeginterferon alfa-2b, Ropeg + anti PD-1, PEG-IL-2, PEG-Cytokines, PD-1-IL-2v, NY-ESO-1 TCR-T, among others. It derives revenue from medicine products sales from contracts with customers.
82GF Score

Get the complete analysis for FRA:8Z1

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.50
Price
€14.50
GF Value